APA (7th ed.) Citation

Yang, F., Qian, X., Qin, W., Deng, R., Wu, X., Qin, J., . . . Zhu, X. (2013). Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 Has a Therapeutic Potential and Sensitizes Cisplatin in Nasopharyngeal Carcinoma. PloS one, 8(3), e59879. https://doi.org/10.1371/journal.pone.0059879

Chicago Style (17th ed.) Citation

Yang, Fen, Xiao-Jun Qian, Wei Qin, Rong Deng, Xiao-Qi Wu, Juan Qin, Gong-Kan Feng, and Xiao-Feng Zhu. "Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 Has a Therapeutic Potential and Sensitizes Cisplatin in Nasopharyngeal Carcinoma." PloS One 8, no. 3 (2013): e59879. https://doi.org/10.1371/journal.pone.0059879.

MLA (9th ed.) Citation

Yang, Fen, et al. "Dual Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 Has a Therapeutic Potential and Sensitizes Cisplatin in Nasopharyngeal Carcinoma." PloS One, vol. 8, no. 3, 2013, p. e59879, https://doi.org/10.1371/journal.pone.0059879.